Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Henlius Trastuzumab Receives FDA Approval in the United States 2024-04-29 20:18
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 2024-04-29 20:00
Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial 2024-04-29 20:00
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 2024-04-29 20:00
Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024 2024-04-29 19:25
Angel Yeast Publishes 2023 Corporate Social Responsibility Report 2024-04-29 19:00
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations 2024-04-29 19:00
DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative 2024-04-29 15:31
INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics 2024-04-29 12:00
Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024 2024-04-29 10:40
New Business Opportunities in the Silver Economy-Many overseas companies participate in China's largest senior care show 2024-04-29 10:00
OBiO Technology will showcase at American Society of Gene & Cell Therapy 2024-04-29 00:00
MGI Tech opens Customer Experience Center in Brazil to contribute to the advancement of genomics in Latin America 2024-04-28 17:54
Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome 2024-04-26 23:46
United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™ 2024-04-26 23:00
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52% 2024-04-26 23:00
New President Appointed for Nitto Denko Avecia Inc. 2024-04-26 21:20
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers 2024-04-26 21:00
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC 2024-04-26 21:00
FOSUN FOR GOOD, CREATING IMPACT: Fosun International Issued its 2023 ESG Report and the Second Climate Information Disclosures Report 2024-04-26 19:34
1 96 97 98 99 100 1597